Sun Pharmaceuticals

Sun Pharmaceuticals company information, Employees & Contact Information

Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in over 200 counties. It's global presence is supported by 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multicultural workforce comprising over 50 nationalities. It has around 2000 research scientists working in multiple R&D centres equipped with cutting-edge enabling technologies for research with R&D spends over 7-8% of annual revenues.

Company Details

Employees
1.32K
Founded
-
Address
Goregaon (E), Sun House,cts No. 201 B/1,india
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Mumbai, Maharashtra
Looking for a particular Sun Pharmaceuticals employee's phone or email?

Sun Pharmaceuticals Questions

News

Sun Pharma Announces Appointment of Richard Ascroft as CEO North America - PR Newswire

Sun Pharma Announces Appointment of Richard Ascroft as CEO North America PR Newswire

Sun Pharma to Open New Plainsboro Headquarters - communitynews.org

Sun Pharma to Open New Plainsboro Headquarters communitynews.org

Sun Pharma Completes its Acquisition of Checkpoint Therapeutics - PR Newswire

Sun Pharma Completes its Acquisition of Checkpoint Therapeutics PR Newswire

Sun Pharmaceuticals Industries Ltd - Fortune India

Sun Pharmaceuticals Industries Ltd Fortune India

Sun Pharma to Declare Q4 Results on May 22, 2025 - Construction World India

Sun Pharma to Declare Q4 Results on May 22, 2025 Construction World India

Sun Pharma Announces Launch of LEQSELVI™ (deuruxolitinib) in the United States for the Treatment of Severe Alopecia Areata - PR Newswire

Sun Pharma Announces Launch of LEQSELVI™ (deuruxolitinib) in the United States for the Treatment of Severe Alopecia Areata PR Newswire

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata - Business Wire

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata Business Wire

Taro Shareholders Approve Merger with Sun Pharma - PR Newswire Canada

Taro Shareholders Approve Merger with Sun Pharma PR Newswire Canada

Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis - PR Newswire

Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis PR Newswire

Sun Pharmaceutical Industries Share Price Today - Sun Pharmaceutical Industries Stock Price Live NSE/BSE - CNBC TV18

Sun Pharmaceutical Industries Share Price Today - Sun Pharmaceutical Industries Stock Price Live NSE/BSE CNBC TV18

Zydus and Sun Pharma Sign Licensing Agreement for Co-Marketing of Desidustat, a Critical Treatment for Chronic Kidney Disease Patients in India - Business Wire India

Zydus and Sun Pharma Sign Licensing Agreement for Co-Marketing of Desidustat, a Critical Treatment for Chronic Kidney Disease Patients in India Business Wire India

SUNPHARMA Stock Price and Chart — NSE:SUNPHARMA - TradingView

SUNPHARMA Stock Price and Chart — NSE:SUNPHARMA TradingView

Sun Pharma to Acquire Checkpoint Therapeutics - PR Newswire

Sun Pharma to Acquire Checkpoint Therapeutics PR Newswire

Sun Pharma launches (Pr)CEQUA™ (cyclosporine ophthalmic solution 0.09% w/v), the first dry eye treatment with nanomicellar (NCELL™) technology*, in Canada - PR Newswire Canada

Sun Pharma launches (Pr)CEQUA™ (cyclosporine ophthalmic solution 0.09% w/v), the first dry eye treatment with nanomicellar (NCELL™) technology*, in Canada PR Newswire Canada

Sun Pharma Announces Health Canada Approval of (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Nodular Acne - PR Newswire Canada

Sun Pharma Announces Health Canada Approval of (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Nodular Acne PR Newswire Canada

Sun Pharma Canada Launches (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Acne - PR Newswire Canada

Sun Pharma Canada Launches (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Acne PR Newswire Canada

Sun Pharma Presents LEQSELVI™ (deuruxolitinib) Data Highlighting Clinical Efficacy & Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference - PR Newswire

Sun Pharma Presents LEQSELVI™ (deuruxolitinib) Data Highlighting Clinical Efficacy & Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference PR Newswire

Sun Pharma Announces Drizalma Sprinkle™ (duloxetine delayed-release capsules) is Now Covered by Most Medicare Part D Plans - PR Newswire

Sun Pharma Announces Drizalma Sprinkle™ (duloxetine delayed-release capsules) is Now Covered by Most Medicare Part D Plans PR Newswire

Sun Pharma and Cassiopea announce the expiry of the HSR Act process and the successful consummation of their Winlevi® (clascoterone cream 1%) agreement - PR Newswire

Sun Pharma and Cassiopea announce the expiry of the HSR Act process and the successful consummation of their Winlevi® (clascoterone cream 1%) agreement PR Newswire

Sun Pharma Canada Launches (PR)WINLEVI® (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne - PR Newswire Canada

Sun Pharma Canada Launches (PR)WINLEVI® (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne PR Newswire Canada

Top Sun Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant